Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-25

Clinical Trial Update: A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes Patients [Phase 3]

View source ↗

Summary

Phase 3 study comparing basal-bolus regimens with lispro insulin in adults with type 2 diabetes; the trial is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humalog (insulin lispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2011-03-25